PANBELA THERAPEUTICS

panbela-therapeutics-logo

Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The companyโ€™s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Panbela Therapeutics has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, Arizona, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre in Adelaide, Australia. Founded in 2011, the company is based in Minnesota, United States.

#SimilarOrganizations #People #Financial #Website #More

PANBELA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2011-01-01

Address:
Minnesota City, Minnesota, United States

Country:
United States

Website Url:
http://www.sunbiopharma.com

Total Employee:
11+

Status:
Active

Contact:
(952)479-1196

Email Addresses:
[email protected]

Total Funding:
22.88 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud Gravatar Profiles OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aratana-therapeutics-logo

Aratana Therapeutics

Aratana Therapeutics develops innovative therapies for the animal health industry.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

Current Employees Featured

not_available_image

David B. Kaysen
David B. Kaysen President, Chief Executive Officer @ Panbela Therapeutics
President, Chief Executive Officer

thomas-x-neenan_image

Thomas X. Neenan
Thomas X. Neenan Co-Founder, Chief Executive Officer & President @ Panbela Therapeutics
Co-Founder, Chief Executive Officer & President

suzanne-gagnon_image

Suzanne Gagnon
Suzanne Gagnon CMO @ Panbela Therapeutics
CMO
2014-01-01

not_available_image

Paul M. Herron
Paul M. Herron Chief Financial Officer & Vice President-Business Development @ Panbela Therapeutics
Chief Financial Officer & Vice President-Business Development

tammy-groene_image

Tammy Groene
Tammy Groene Vice President Operations @ Panbela Therapeutics
Vice President Operations
2020-12-01

not_available_image

Clifford F. Mccurdy
Clifford F. Mccurdy Chairman & Chief Executive Officer @ Panbela Therapeutics
Chairman & Chief Executive Officer

Founder


not_available_image

Michael T. Cullen

thomas-x-neenan_image

Thomas X. Neenan

Stock Details


Company's stock symbol is NASDAQ:PBLA

Acquisitions List

Date Company Article Price
2022-02-22 Cancer Prevention Pharmaceuticals Cancer Prevention Pharmaceuticals acquired by Panbela Therapeutics N/A
2015-09-07 Cimarron Medical Cimarron Medical acquired by Panbela Therapeutics N/A

Investors List

institute-for-the-commercialization-of-public-research_image

Florida Institute for the Commercialization of Florida Technology

Florida Institute for the Commercialization of Florida Technology investment in Venture Round - Panbela Therapeutics

Official Site Inspections

http://www.sunbiopharma.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 3.33.130.190
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Panbela Therapeutics"

Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.

MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment โ€ฆSee details»

Panbela Therapeutics - Crunchbase Company Profile

Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The โ€ฆSee details»

Sun BioPharma | VentureRadar

Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and MGI Pharma, a biopharmaceutical company focused on โ€ฆSee details»

www.sunbiopharma.com

Www.sunbiopharma.comSee details»

David Kaysen Named President & CEO of Sun BioPharma

Sep 16, 2015 Kaysen brings to Sun BioPharma more than 25 years of healthcare clinical development, commercial and public company achievements. He joins the Company as its โ€ฆSee details»

Sun BioPharma renames to Panbela Therapeutics

Dec 2, 2020 The name change takes effect Dec. 2. Discover more about S&P Globalโ€™s offeringsSee details»

Sun BioPharma Company Overview, Contact Details

Sun BioPharma, Inc. hired Jennifer K. Simpson as President and Chief Executive Officer on Jul 16th '20. · Company founder Michael T. Cullen, M.D. will continue to serve as Executive โ€ฆSee details»

Sun Biopharma Inc. | Key People and Executives - statinvestor.com

Sun BioPharma Inc. is a clinical-stage biopharmaceutical company, which engages in the development of disruptive therapeutics for medical purposes. It focuses on development โ€ฆSee details»

Sun BioPharma, Inc. Changes Name to Panbela Therapeutics

Dec 1, 2020 Contact Information: Investors: James Carbonara Hayden IR (646) 755-7412 [email protected] Media: Tammy Groene Panbela Therapeutics, Inc. (952) 479-1196 โ€ฆSee details»

2019 Annual Report

SUN BIOPHARMA, INC. 712 Vista Boulevard #305 Waconia, Minnesota 55387 PROXY STATEMENT The Board of Directors of Sun BioPharma, Inc. (โ€œour Companyโ€) is soliciting โ€ฆSee details»

Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.

Dec 1, 2020 --Sun BioPharma, Inc., a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of โ€ฆSee details»

Sun BioPharma, Inc. Announces Leadership Changes

Organization. Effective October 31, 2018, David B. Kaysen is stepping down as President, CEO and Board member of Sun BioPharma, Inc. and its wholly owned subsidiary, Sun BioPharma โ€ฆSee details»

Sun Biopharma - Overview, News & Similar companies - ZoomInfo

Mar 24, 2022 Sun BioPharma Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. T he company's initial โ€ฆSee details»

Sun BioPharma, Inc. Announces Leadership Changes

Oct 31, 2018 Contact Data Contact Information: Investor & Media Contact: Susan Horvath โ€“ Sun BioPharma, Inc. 952 479 1196See details»

Sun BioPharma names Jennifer Simpson as president and CEO

Jul 17, 2020 Sun BioPharma (OTCQB:SNBP) appointed Jennifer Simpson as president and CEO, replacing co-founder Michael Cullen, who will continue to serve as the companyโ€™s โ€ฆSee details»

Sun BioPharma, Inc. Company Profile & Introduction - Tiger Brokers

Sun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the โ€ฆSee details»

Sun BioPharma, Inc. Provides Business Update and Reports Q3

Nov 12, 2020 Sun BioPharma Inc. is dedicated to treating patients with pancreatic cancer and exploring SBP-101โ€™s potential for efficacy in combination with other agents and in treating โ€ฆSee details»

Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP โ€ฆ

Jul 1, 2020 UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, โ€ฆSee details»

Sun BioPharma, Inc. Announces Appointment of Susan Horvath as โ€ฆ

As an organization. It is with gratitude and respect that we send our best wishes with Scott as he moves on to a new opportunity.โ€ About SBP-101 SBP-101 is a first-in-class, proprietary โ€ฆSee details»

Three-medical linkage in China: trend evolution and obstacle ...

Apr 2, 2025 This study adhered to the general standards for healthcare service ratings set by the World Health Organization and World Bank, as well as the specific requirements outlined in โ€ฆSee details»

linkstock.net © 2022. All rights reserved